Vancouver, BC -- (SBWIRE) -- 03/17/2021 -- The global cancer imaging systems market is projected to be worth USD 12.24 Billion by 2027, according to a current analysis by Emergen Research. The cancer imaging systems market is observing high demand attributed to the increasing incidence of cancer. Cancer significantly impacts the societal and economic growth in the US and worldwide and is a major contributor to the cost burden of disease. It has been anticipated that 1,806,590 new cancer cases are likely to be diagnosed in the US in 2020, and 606,520 deaths will occur owing to the disease.

Growing technological advancements and increased investments in cancer imaging are causative of the rapid growth of the market. Hologic, Inc., in November 2019, received approval from the US Food and Drug Administration (FDA) for its 3DQuorum™ Imaging Technology, driven by Genius AI™. The technology works simultaneously with Hologic's Clarity HD™ high-resolution imaging technology and helps radiologists reduce tomosynthesis image volume by 66.0%. The breast imaging system owing to such advancements would produce higher-resolution 3D images, better workflow, and an improved mammography experience for patents necessitating low radiation dose.

You Can Download Free Sample PDF Copy of Cancer Imaging Systems Market at https://www.emergenresearch.com/request-sample/222

Furthermore, application of Porters Five Forces Analysis to determine the status of various aspects such as the capability of both the suppliers and customers, threats posed by different substitutes, the intensity of competition and promising new vendors makes the study a valuable resource. The researchers behind the market intelligence report examine the weaknesses, strengths, opportunities, and restraints expected to shape the progress of the Cancer Imaging Systems market for the forecast period, 2020 to 2027. The market intelligence report includes detailed statistics on market segmentation based on product value, application, classification, and sale.

Key Highlights From The Report
In July 2019, Agilent Technologies Inc. made an announcement about the signing of an agreement to buy BioTek Instruments, a private firm, for USD 1.17 billion. BioTek is involved in designing, producing, and distributing groundbreaking life science instrumentation, including cell imaging systems.
MRI offers the benefit of imaging soft body tissue parts that are occasionally hard to view using other types of modalities. MRI is excellent at identifying and locating some cancers. Moreover, an MRI deploying contrast dye is the most appropriate brain and spinal cord tumor imaging technique.
Lung cancer is a common type of cancer in men and the third-leading cancer type in women with 2 million novel cases in the year 2018. Hungary, Serbia, and New Caledonia (France) were the top three countries with the highest disease rate in 2018.
Diagnostics centers are projected to grow at the fastest rate of 10.0% in the forecast period. Diagnostic centers are fitted out with the requisite imaging system and specialist staff, as well as healthcare personnel, for assisting in the process of detecting diseases in individuals displaying specific symptoms.
The market in the North American region held the largest market share in 2019, owing to a high adoption of advanced imaging technologies, a rising incidence of cancer, established healthcare infrastructure, and undertaking of various initiatives to create awareness about the disease.
Key participants include GE Healthcare, Hitachi Medical, Becton, Dickinson, and Company, Thermo Fisher Scientific Inc., CR Bard Inc., Agilent Technologies, Abbott, Illumina Inc., Roche, and Philips Healthcare, among others.

You Can Download Free Sample PDF Copy of Cancer Imaging Systems Market at https://www.emergenresearch.com/request-sample/222

Imaging Systems Outlook (Revenue, USD Billion; 2017-2027)
Mammography
Computed Tomography (CT)
Magnetic Resonance Imaging (MRI)
Ultrasound
Positron Emission Tomography (PET)
Others

Application Outlook (Revenue, USD Billion; 2017-2027)
Breast Cancer
Lung Cancer
Colorectal Cancer
Melanoma
Others

End-Users Outlook (Revenue, USD Billion; 2017-2027)
Hospitals & Clinics
Diagnostic Centers
Others

Helping you establish a strong foothold in the industry
The Cancer Imaging Systems report highlights set of information related to pricing and the category of customers who are more than willing to pay for certain products and services. The information on opportunities as well as product features, determine which offerings or benefits command sale and identify the communications channels used by the market leaders to create premium positioning strategies as well as attract broadest share.

Apart from the above mentioned content the researchers go an extra mile to define the distinct usage occasions and lists the customer segments to leverage the brand and identify future opportunities. Besides, the subject matter expert segment the target customers purely based on their consumption patterns.

Regional Outlook (Revenue, USD Million; 2017–­­­2027)
North America
Europe
Asia Pacific
Latin America
Middle East & Africa
Table of Content

Read more@ https://www.emergenresearch.com/industry-report/cancer-imaging-systems-market

Table of Content
Chapter 1. Methodology & Sources
1.1. Market Definition
1.2. Research Scope
1.3. Methodology
1.4. Research Sources
1.4.1. Primary
1.4.2. Secondary
1.4.3. Paid Sources
1.5. Market Estimation Technique
Chapter 2. Executive Summary
2.1. Summary Snapshot, 2019-2027
Chapter 3. Key Insights
Chapter 4. Cancer Imaging Systems Market Segmentation & Impact Analysis
Chapter 5. Cancer Imaging Systems Market By Product Type Insights & Trends, Revenue (USD Million)
Chapter 6. Cancer Imaging Systems Market By Application Insights & Trends Revenue (USD Million)
Chapter 7. Cancer Imaging Systems Market Regional Outlook
Continued…